These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 37555989)

  • 1. What is the impact of ferroptosis on diabetic cardiomyopathy: a systematic review.
    Lou X; Zhang Y; Guo J; Gao L; Ding Y; Zhuo X; Lei Q; Bian J; Lei R; Gong W; Zhang X; Jiao Q
    Heart Fail Rev; 2024 Jan; 29(1):1-11. PubMed ID: 37555989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis: roles and molecular mechanisms in diabetic cardiomyopathy.
    Zhao Y; Pan B; Lv X; Chen C; Li K; Wang Y; Liu J
    Front Endocrinol (Lausanne); 2023; 14():1140644. PubMed ID: 37152931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy.
    Du S; Shi H; Xiong L; Wang P; Shi Y
    Front Endocrinol (Lausanne); 2022; 13():1011669. PubMed ID: 36313744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of Ferroptosis and Its Role in Type 2 Diabetes Mellitus.
    Sha W; Hu F; Xi Y; Chu Y; Bu S
    J Diabetes Res; 2021; 2021():9999612. PubMed ID: 34258295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial Dysfunction and Diabetic Cardiomyopathy.
    Wang M; Li Y; Li S; Lv J
    Front Endocrinol (Lausanne); 2022; 13():851941. PubMed ID: 35464057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy.
    Peng ML; Fu Y; Wu CW; Zhang Y; Ren H; Zhou SS
    Front Endocrinol (Lausanne); 2022; 13():907757. PubMed ID: 35784531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis: A New Mechanism in Diabetic Cardiomyopathy.
    Song Z; Wang J; Zhang L
    Int J Med Sci; 2024; 21(4):612-622. PubMed ID: 38464828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway.
    Li F; Hu Z; Huang Y; Zhan H
    J Cardiothorac Surg; 2023 Jul; 18(1):223. PubMed ID: 37430319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane
    Wang X; Chen X; Zhou W; Men H; Bao T; Sun Y; Wang Q; Tan Y; Keller BB; Tong Q; Zheng Y; Cai L
    Acta Pharm Sin B; 2022 Feb; 12(2):708-722. PubMed ID: 35256941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of NLRP3 gene knockdown on pyroptosis and ferroptosis in diabetic cardiomyopathy injury.
    Wang J; Li Y; Li L; Liang H; Ye H; Kang P; Li Z; Yu Y; Gao Q
    BMC Cardiovasc Disord; 2024 Jul; 24(1):351. PubMed ID: 38987672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial oxidative stress mediated Fe-induced ferroptosis via the NRF2-ARE pathway.
    Chen GH; Song CC; Pantopoulos K; Wei XL; Zheng H; Luo Z
    Free Radic Biol Med; 2022 Feb; 180():95-107. PubMed ID: 35045311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis in mitochondrial cardiomyopathy.
    Ahola S; Langer T
    Trends Cell Biol; 2024 Feb; 34(2):150-160. PubMed ID: 37419738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products and reactive oxygen species: uncovering the potential role of ferroptosis in diabetic complications.
    Chen Y; Meng Z; Li Y; Liu S; Hu P; Luo E
    Mol Med; 2024 Sep; 30(1):141. PubMed ID: 39251935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis.
    Fang X; Cai Z; Wang H; Han D; Cheng Q; Zhang P; Gao F; Yu Y; Song Z; Wu Q; An P; Huang S; Pan J; Chen HZ; Chen J; Linkermann A; Min J; Wang F
    Circ Res; 2020 Jul; 127(4):486-501. PubMed ID: 32349646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLIN5 Suppresses Lipotoxicity and Ferroptosis in Cardiomyocyte via Modulating PIR/NF-κB Axis.
    Shen X; Zhang J; Zhou Z; Yu R
    Int Heart J; 2024 May; 65(3):537-547. PubMed ID: 38749744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac oxidative stress in diabetes: Mechanisms and therapeutic potential.
    Faria A; Persaud SJ
    Pharmacol Ther; 2017 Apr; 172():50-62. PubMed ID: 27916650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ferroptosis in response to graphene quantum dots through mitochondrial oxidative stress in microglia.
    Wu T; Liang X; Liu X; Li Y; Wang Y; Kong L; Tang M
    Part Fibre Toxicol; 2020 Jul; 17(1):30. PubMed ID: 32652997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative Stress Signaling Mediated Pathogenesis of Diabetic Cardiomyopathy.
    Tang Z; Wang P; Dong C; Zhang J; Wang X; Pei H
    Oxid Med Cell Longev; 2022; 2022():5913374. PubMed ID: 35103095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoamine oxidase-A is an important source of oxidative stress and promotes cardiac dysfunction, apoptosis, and fibrosis in diabetic cardiomyopathy.
    Umbarkar P; Singh S; Arkat S; Bodhankar SL; Lohidasan S; Sitasawad SL
    Free Radic Biol Med; 2015 Oct; 87():263-73. PubMed ID: 26122707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous spermidine alleviates diabetic cardiomyopathy via suppressing reactive oxygen species, endoplasmic reticulum stress, and Pannexin-1-mediated ferroptosis.
    Sun J; Xu J; Liu Y; Lin Y; Wang F; Han Y; Zhang S; Gao X; Xu C; Yuan H
    Biomol Biomed; 2023 Sep; 23(5):825-837. PubMed ID: 36946337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.